Effects of SGLT-2 inhibitors and GLP-1 receptor agonists on liver function in patients with non-alcoholic fatty liver disease and type 2 diabetes. - Guo W; Li W; Li X; Shi W; Yan Y; Yan T; Zhou J; Huang Y (Frontiers in endocrinology, 2026)